Mosapride (Mosapride Citrate Hydrate)

Adult dose

Adults: Administer 15 mg per day as anhydrous mosapride citrate orally in 3 divided doses before or after meals.

This medicine contains lactose and should not be used by individuals with genetic issues that prevent them from digesting lactose. Such individuals may have galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. While taking this medicine, side effects such as diarrhea, loose stools, dry mouth, and fatigue may occur. Rarely, severe side effects such as fulminant hepatitis or jaundice may occur, so it is essential to monitor your condition closely. If any unusual symptoms arise, stop taking the medicine immediately and consult a doctor. Additionally, various symptoms such as rash, hives, blood abnormalities, abdominal pain, nausea, vomiting, dizziness, and palpitations may occur, so caution is advised. In particular, if symptoms do not improve after two weeks of use, long-term use should be avoided. The effectiveness of this medicine may decrease when taken in combination with anticholinergic drugs, so the dosage interval should be adjusted or a physician should be consulted. Women who are pregnant or may become pregnant should use this medication cautiously, as its safety has not been established. If breastfeeding, it is recommended to avoid taking this medicine or to stop breastfeeding, as the drug may be passed to breast milk. Safety has not been thoroughly established for children, so it is best to avoid using this medicine in children. Elderly patients may experience decreased kidney and liver function, so their condition should be closely monitored while taking the medication, and if any abnormal symptoms occur, the dosage should be reduced accordingly. This medicine should be kept out of reach of children and should not be transferred to another container, as this may compromise its quality.

• Diarrhea
• loose stools
• dry mouth
• fatigue
• eosinophilia
• increased triglycerides
• elevated AST
• elevated ALT
• elevated ALP
• elevated γ-GTP

This medicine should be stored in a tightly sealed container to prevent air and moisture exposure and should be kept at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medicine.

Appearance

White, oblong, film-coated tablet with a break line

Package unit

30 tablets/bottle, 300 tablets/bottle